ArticleJournal of the American Heart Association2021

Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.

Xuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.